Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | BIO |
---|---|---|
09:32 ET | 1983 | 305.934 |
09:35 ET | 100 | 308.54 |
09:37 ET | 100 | 310.93 |
09:39 ET | 417 | 309.7 |
09:42 ET | 100 | 308.71 |
09:44 ET | 400 | 307.88 |
09:46 ET | 858 | 310.4 |
09:48 ET | 300 | 310.415 |
09:50 ET | 875 | 309.3093 |
09:51 ET | 100 | 308.65 |
09:53 ET | 658 | 309.138 |
09:57 ET | 100 | 308.6 |
10:02 ET | 167 | 309.1756 |
10:04 ET | 200 | 309.67 |
10:06 ET | 200 | 309.44 |
10:09 ET | 200 | 309.32 |
10:11 ET | 100 | 310.02 |
10:13 ET | 342 | 309.23 |
10:18 ET | 200 | 309.13 |
10:20 ET | 600 | 308.73 |
10:22 ET | 326 | 309.005 |
10:24 ET | 800 | 309.38 |
10:26 ET | 1182 | 309.22 |
10:27 ET | 200 | 309.03 |
10:31 ET | 600 | 309.18 |
10:33 ET | 400 | 308.36 |
10:38 ET | 100 | 307.21 |
10:40 ET | 300 | 307.18 |
10:44 ET | 650 | 307.54 |
10:47 ET | 300 | 307.97 |
10:49 ET | 400 | 308 |
11:00 ET | 1522 | 308.65 |
11:02 ET | 200 | 308.53 |
11:03 ET | 200 | 307.65 |
11:12 ET | 500 | 307.325 |
11:14 ET | 300 | 307.29 |
11:18 ET | 100 | 307.02 |
11:20 ET | 113 | 306.9785 |
11:23 ET | 100 | 306.135 |
11:27 ET | 900 | 306.1 |
11:32 ET | 755 | 306.02 |
11:34 ET | 546 | 306.26 |
11:36 ET | 561 | 306.39 |
11:41 ET | 100 | 304.73 |
11:43 ET | 100 | 304.7 |
11:45 ET | 737 | 303.73 |
11:50 ET | 3049 | 304.46 |
11:52 ET | 100 | 304.095 |
11:57 ET | 200 | 305.09 |
11:59 ET | 100 | 304.575 |
12:01 ET | 423 | 305.735 |
12:03 ET | 100 | 305.62 |
12:15 ET | 383 | 305.11 |
12:17 ET | 300 | 305.125 |
12:21 ET | 2600 | 305.91 |
12:24 ET | 3649 | 306.04 |
12:26 ET | 2059 | 305.21 |
12:44 ET | 100 | 304.59 |
12:51 ET | 200 | 304.33 |
12:57 ET | 103 | 303.89 |
01:00 ET | 300 | 304.18 |
01:06 ET | 104 | 304.93 |
01:08 ET | 314 | 305.18 |
01:11 ET | 100 | 304.765 |
01:15 ET | 100 | 304.44 |
01:18 ET | 100 | 304.22 |
01:20 ET | 216 | 304.42 |
01:26 ET | 200 | 304.305 |
01:27 ET | 100 | 304.18 |
01:29 ET | 200 | 304.36 |
01:33 ET | 100 | 304.49 |
01:40 ET | 100 | 304.91 |
01:42 ET | 348 | 304.495 |
01:45 ET | 100 | 304.065 |
01:54 ET | 300 | 304.22 |
02:02 ET | 300 | 304.335 |
02:07 ET | 466 | 304.505 |
02:09 ET | 346 | 304.095 |
02:12 ET | 721 | 304.225 |
02:14 ET | 102 | 304.1285 |
02:16 ET | 187 | 304.28 |
02:20 ET | 500 | 304.265 |
02:23 ET | 193 | 304.32 |
02:25 ET | 154 | 304.5249 |
02:27 ET | 100 | 304.725 |
02:30 ET | 550 | 304.54 |
02:36 ET | 271 | 304.54 |
02:38 ET | 200 | 304.51 |
02:39 ET | 300 | 304.86 |
02:41 ET | 200 | 304.6 |
02:45 ET | 100 | 304.61 |
02:50 ET | 477 | 304.66 |
02:52 ET | 200 | 305 |
02:54 ET | 475 | 304.525 |
02:56 ET | 210 | 304.74 |
02:57 ET | 100 | 304.47 |
02:59 ET | 300 | 304.35 |
03:01 ET | 200 | 304.35 |
03:03 ET | 100 | 304.48 |
03:10 ET | 300 | 304.18 |
03:12 ET | 227 | 304.49 |
03:14 ET | 300 | 304.69 |
03:17 ET | 400 | 304.9 |
03:19 ET | 200 | 304.75 |
03:28 ET | 100 | 304.23 |
03:30 ET | 400 | 304.185 |
03:32 ET | 500 | 303.99 |
03:33 ET | 200 | 304.15 |
03:35 ET | 200 | 303.945 |
03:37 ET | 100 | 303.91 |
03:39 ET | 800 | 304.105 |
03:42 ET | 400 | 303.735 |
03:44 ET | 4879 | 304.18 |
03:48 ET | 2147 | 303.79 |
03:50 ET | 1000 | 303.55 |
03:51 ET | 2095 | 303.4 |
03:53 ET | 200 | 303.565 |
03:55 ET | 3851 | 303.485 |
03:57 ET | 2054 | 303.485 |
04:00 ET | 51398 | 304.13 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Bio Rad Laboratories Inc | 8.9B | -54.7x | --- |
Stevanato Group SpA | 8.2B | 46.1x | --- |
Repligen Corp | 8.9B | 78.4x | +46.58% |
Teleflex Inc | 10.9B | 27.0x | +6.35% |
Penumbra Inc | 8.6B | 215.5x | --- |
DENTSPLY SIRONA Inc | 6.8B | -31.5x | --- |
Bio-Rad Laboratories, Inc. manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Life Science segment markets and develops, manufactures and markets a portfolio of various products that serves a global customer base. The segment is focused on specific segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology and food safety. Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. Its products address specific niches within the in vitro diagnostics (IVD) test market.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $8.9B |
---|---|
Revenue (TTM) | $2.7B |
Shares Outstanding | 29.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.89 |
EPS | $-5.56 |
Book Value | $324.89 |
P/E Ratio | -54.7x |
Price/Sales (TTM) | 3.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | 13.06% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.